Albiflorin alleviates ox-ldl-induced human umbilical vein endothelial cell injury through irak1/tak1 pathway

HIGHLIGHTS

• who: Yeling Liu and colleagues from the Department of Pharmacy, Tai`an City Central Hospital, Tai`an, Shandong, China have published the paper: Albiflorin Alleviates Ox-LDL-Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway, in the Journal: BioMed Research International of 13/05/2022
• how: The authors explored the influences of AF on the related biological functions (viability cholesterol eufb04ux inflammation ROS and apoptosis) of AS model cells. To further confirm this hypothesis the authors conducted a rescue experiment in Ox-LDL-induced HUVECs.
• future: It has become a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.